Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Carassa

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Glaucoma|October 2, 2003
Failed non-penetrating surgeryStefano Gandolfi, Tarek Shaarawy, Roberto Carassa
Advances in Therapy|July 12, 2021
Efficacy and Safety of PreserFlo<sup>®</sup> MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective StudyLuciano Quaranta, Eleonora Micheletti, Roberto Carassa, et al.
Journal of Glaucoma|June 17, 2006
An evaluation of the rate of nonresponders to latanoprost therapyLuca Rossetti, Stefano Gandolfi, Carlo Traverso, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensusJohn Thygesen, Reinhard Burk, Roberto Carassa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Glaucoma|October 2, 2003
Failed non-penetrating surgeryStefano Gandolfi, Tarek Shaarawy, Roberto Carassa
Advances in Therapy|July 12, 2021
Efficacy and Safety of PreserFlo<sup>®</sup> MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective StudyLuciano Quaranta, Eleonora Micheletti, Roberto Carassa, et al.
Journal of Glaucoma|June 17, 2006
An evaluation of the rate of nonresponders to latanoprost therapyLuca Rossetti, Stefano Gandolfi, Carlo Traverso, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensusJohn Thygesen, Reinhard Burk, Roberto Carassa, et al.
Pageof 1